Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2003
08/13/2003CN1436234A Composition and methods for therapy and diagnosis of prostate cancer
08/13/2003CN1436195A Integrin binding peptide derivatives
08/13/2003CN1436086A Interferon for treatment of multiple sclerosis
08/13/2003CN1435485A Recombinant DNA sequence, coded immune fusion protein and expression method
08/13/2003CN1435432A Keratin solution and solid preparing process
08/13/2003CN1435431A Polypeptides matter, method for preparing same and use thereof
08/13/2003CN1435425A Ribosomal deactivated protein gene
08/13/2003CN1117868C Blackcurrant promoters and genes
08/13/2003CN1117866C Method of introducing predetermined alteration in target sequence of genome of cell having nucleus
08/13/2003CN1117863C Surface anchoring vector and system for foreign proteins thereof
08/13/2003CN1117862C Live attenuated RTX-producing bacteria of family pasteurellaceae
08/13/2003CN1117861C Novel gene originating in corynebacterium and use thereof
08/13/2003CN1117859C Method of cultivating bacteria producing proteins that are expressed in temp. regulated manner
08/13/2003CN1117762C Spray dried erythropoietin
08/13/2003CN1117761C Recombinant virus capable of specifically killing EB virus associated tumor and construction method thereof
08/13/2003CN1117760C Lysosomal enzyme-cleavable antitumor drug conjugates
08/12/2003US6605764 Pathogen- or elicitor-inducible transcription regulatory element from the tobacco 5-EPI-aristolochene synthase gene and plants transformed therewith
08/12/2003US6605712 Isolated DNA comprising a radiation inducible promoter linked to a region encoding a polypeptide; use for regulating polypeptide expression and inhibiting tumor growth; anticarcinogenic agent
08/12/2003US6605711 NY-ESO-1 peptide derivatives, and uses thereof
08/12/2003US6605710 Gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages
08/12/2003US6605709 Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics
08/12/2003US6605706 Gene expressing polypeptide in prokaryotic cells; harvesting, solubilizing cells in buffer with chaotropic and reducing agents; dilution
08/12/2003US6605704 Plant-origin regulator protein and nucleic acid encoding the same
08/12/2003US6605703 Deletion of the Hck binding region in the IL-6 receptor
08/12/2003US6605702 Protein for use in the treatment of inflammatory defects and asthma
08/12/2003US6605701 Insecticidal protein against the Western corn rootworm
08/12/2003US6605700 Human patched genes and proteins, and uses related thereto
08/12/2003US6605699 Diagnosing cancer, inflammation, and autoimmune diseases
08/12/2003US6605698 Antifungal peptides and composition thereof
08/12/2003US6605697 Modified E. coli enterotoxin II signal peptide and a microorganism expressing a fusion protein of a said peptide and a heterologous protein
08/12/2003US6605696 Vaccines for pig porcine proliferative enteropathy (PPE)
08/12/2003US6605592 Protein HOFNF53
08/12/2003US6605588 Amino acid sequence of SEQ ID NO:6
08/12/2003US6605467 Fusion protein comprising the whole or part of the PP65 protein of human CMV, useable in particular for preparing a vaccine
08/12/2003US6605464 Expressible polynucleotides encoding eukaryotic heat shock proteins
08/12/2003US6605462 Bacillus thuringiensis isolates active against weevils
08/12/2003US6605457 Influenza vaccine
08/12/2003US6605455 Polynucleotides used to transform or transfect cells; gene expression
08/12/2003US6605450 Iron regulation of the PpSEC10 transcriptional regulatory region of Pichia pastoris and methods of use
08/12/2003US6605449 Saturation mutagenesis to produce progenitor polynucleotide library
08/12/2003US6605443 Drug screening for compound which disrupts Smad7 transforming growth-beta factor superfamily signal transduction inhibitory activity
08/12/2003US6605442 Methods of testing drugs or agents that modulate the activity of receptor recognition factors
08/12/2003US6605441 Antibodies against fibroblast growth factor 11
08/12/2003US6605437 Screening methods for compounds useful for the treatment of body weight disorders, including obesity
08/12/2003US6605426 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
08/12/2003US6605425 Immunogenic determinant for use in the diagnosis of Kaposi's sarcoma
08/12/2003US6605287 Vaccines for Chlamydia psittaci infections
08/12/2003US6605286 Delivery of biologically active polypeptides
08/12/2003US6605284 Gene coding for the measles virus mutant antigen
08/12/2003US6605283 Isolated nucleic acid sequence encoding open reading frame of avian pneumovirus (Colorado) Type C strain attachment glycoprotein
08/12/2003US6605281 Replicon for delivery of transgene for episomal gene expression in mammalian host cell comprising transgene and first and second sequences, all under control of human papillomavirus, incorporated within at least one plasmid
08/12/2003US6605280 Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18
08/12/2003US6605279 Nucleotide sequences coding preferential polypeptide for use in intensifying immunological response
08/12/2003US6605276 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
08/12/2003US6605272 Methods of using zalpha11 ligand
08/12/2003US6605271 Activating cell proliferation and differentiation in hematopoietic cells; obtain cells, incubate with modulator, monitor cell propagation
08/12/2003US6605222 Separation and purification of antihemophilic factors from blood using ion exchangers
08/12/2003CA2248653C Vaccines for treatment of lymphoma and leukemia
08/12/2003CA2216425C Tetanus toxin functional fragment antigen and tetanus vaccine
08/07/2003WO2003065046A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
08/07/2003WO2003065045A2 Diagnostics and therapeutics for diseases associated with the gpr65 receptor
08/07/2003WO2003065042A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells
08/07/2003WO2003065035A1 Method for monitoring and prognosis of disease course of gastrointestinal tumors
08/07/2003WO2003065010A2 Identification of epitopes on staphylococcal enterotoxins that inhibit transcytosis
08/07/2003WO2003065003A2 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
08/07/2003WO2003064992A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases
08/07/2003WO2003064681A2 Assays
08/07/2003WO2003064677A2 Long-acting follicle stimulating hormone analogues and uses thereof
08/07/2003WO2003064676A2 Diagnostic and therapeutic methods using the h37 tumor suppressor gene
08/07/2003WO2003064666A1 Adenoviral vectors for modulating the cellular activities associated with pods
08/07/2003WO2003064664A1 Physiologically regulated erythropoietin- exprressing vector for the treatment of anaemia
08/07/2003WO2003064660A1 Hybrid plasmid pzzsa coding the synthesis of angiogenin protein and escherichia coli bl21 (des) pzzsa strain as the superproducer of the recombinant chimeric protein of human angiogenin
08/07/2003WO2003064658A1 Alpha 1,3 galactosyltransferase mutant pigs
08/07/2003WO2003064656A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
08/07/2003WO2003064649A1 Promoter expressing foreign gene in root and shoot apex
08/07/2003WO2003064647A1 Method of controlling circadian rhythm
08/07/2003WO2003064646A1 Novel peptide and use thereof
08/07/2003WO2003064643A1 Method of designing biomolecular circuit, apparatus for designing biomolecular circuit, program and recording medium
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064628A2 Novel proteins and nucleic acids encoding same
08/07/2003WO2003064616A2 Compounds and methods for inducing growth arrest and apoptosis
08/07/2003WO2003064613A2 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003WO2003064603A2 Nucleic acid molecule encoding iwu-1
08/07/2003WO2003064602A2 Methods of modulating cold sensory perception
08/07/2003WO2003064599A2 Cancer genes
08/07/2003WO2003064595A2 Recombinant herpesvirus of turkeys and use thereof
08/07/2003WO2003064592A2 Inhibitors of autoinducer transporters
08/07/2003WO2003064591A2 Abca8 nucleic acids and proteins, and uses thereof
08/07/2003WO2003064589A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064587A2 Hif-1 alpha proteins mutated in the c-terminal transactivation domain
08/07/2003WO2003064475A1 Novel monoclonal antibody and nematode larval antigens
08/07/2003WO2003064471A2 Gene for peripheral arterial occlusive disease
08/07/2003WO2003064470A2 Regulation of human calcium-activated potassium channel protein
08/07/2003WO2003064469A2 Regulation of human hematopoietin receptor-like protein
08/07/2003WO2003064468A2 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
08/07/2003WO2003064467A1 A complex of a human foxc2 protein and a foxc2-interacting protein
08/07/2003WO2003064464A1 Tolerogenic peptides from myelin basic protein
08/07/2003WO2003064463A2 Pluripotency determining factors and uses thereof
08/07/2003WO2003064462A1 Peg-binding pth or peg-binding pth derivative
08/07/2003WO2003064461A1 Novel anti-viral vsf protein and hybridoma producing the same
1 ... 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 ... 2916